Novo Nordisk to phase out its largest insulin brand in India | India News
In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, Human...
In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, Human...
NEW DELHI: Several domestic drug companies are set to transform diabetes therapy by launching the blockbuster drug Empagliflozin at a...